Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

Discover how quantum-resistant key management secures AI model deployments, protecting against quantum computing threats with advanced encryption and zero-trust strategies.